Manipulation of immune checkpoints by targeted antibodies, such as anti-programmed cell death-1 (PD-1) antibody, has recently emerged as an effective anticancer strategy for many types of cancers including HCC [8]. The gene discussed is PDCD1; the disease is cancer.